Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Viralytics Ltd (OTCQX International:VRACY)

1.70
Delayed Data
As of Aug 03
 -0.25 / -12.82%
Today’s Change
0.70
Today|||52-Week Range
1.95
+129.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$119.6M

Company Description

Viralytics Ltd. is a biotechnology company. The company focuses on the development of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its products include CAVATAK™ and EVATAK™. The company was founded on August 14, 1986 and is headquartered in Sydney, Australia.

Contact Information

Viralytics Ltd.
66 Hunter Street
Sydney New South Wales (nsw) 2000
P:(129) 988-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Malcolm L. McCollChief Executive Officer, Director & MD
Robert C. VickeryChief Financial Officer
Darren ShafrenChief Scientific Officer
Sarah PrinceSecretary